| [ Summary ] |
Chronic kidney disease-mineral and bone disorder (CKD-MBD) defines a triad of interrelated abnormalities of serum biochemistry, bone and vasculature associated with chronic kidney disease (CKD). Accordingly, instead of the classic term "renal osteodystrophy (ROD)", a new term, "CKD-mineral and bone disorders (CKD-MBD)", has been proposed as a new name for this systemic disorder. The Japanese Society for Dialysis Therapy (JSDT) clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients was published in Japan in 2006. In 2012, a new Japanese Society for Dialysis Therapy (JSDT) clinical practice guideline for CKD-MBD is intended to assist practitioners caring for adults and children with CKD stage 3-5 disease, receiving HD therapy, PD therapy or having had a kidney transplant. |